Table 2.
Outcomes of AP according BISAP, APACHE-II, BUN, and haematocrit.
| Rise in haematocrit at 24 hours, variation >0.6% | Rise in BUN at 24 hours, variation >1.87 mg/dl | |||||||
|---|---|---|---|---|---|---|---|---|
| Positive, n = 36 | Negative, n = 374 | p | OR | Positive, n = 65 | Negative, n = 345 | p | OR | |
| Mortality, n (%) | 8 (22.2%) | 15 (4%) | 0.000 | 6.8 (2.6–17.5) | 18 (27.7%) | 5 (1.4%) | 0.000 | 26.0 (9.2–73.4) |
| Persistent multiorgan failure, n (%) | 11 (30.6%) | 20 (5.3%) | 0.000 | 7.7 (3.3–18.0) | 22 (33.8%) | 9 (2.6%) | 0.000 | 19.1 (8.2–44.1) |
| Severe AP, n (%) | 11 (30.6%) | 34 (9.1%) | 0.001 | 4.4 (1.9–9.7) | 25 (38.5%) | 20 (5.8%) | 0.000 | 10.1 (5.1–19.9) |
| APACHE-II > 8 | BISAP > 2 | |||||||
| Positive, n = 120 | Negative, n = 290 | p | OR | Positive, n = 184 | Negative, n = 226 | p | OR | |
| Mortality, n (%) | 16 (13.3%) | 7 (2.4%) | 0.000 | 6.2 (2.4–15.5) | 22 (12%) | 1 (0.4%) | 0.000 | 30.5 (4.0–228.9) |
| Persistent multiorgan failure, n (%) | 21 (17.5%) | 10 (3.4%) | 0.000 | 5.9 (2.7–13.0) | 30 (16.3%) | 1 (0.4%) | 0.000 | 43.8 (5.9–324.6) |
| Severe AP, n (%) | 29 (24.2%) | 16 (5.5%) | 0.000 | 5.4 (2.8–10.5) | 44 (23.9%) | 1 (0.4%) | 0.000 | 70 (9.6–519.0) |
| Haematocrit at admission > 45% | BUN at admission >23.3 mg/dl | |||||||
| Positive, n = 125 | Negative, n = 285 | p | OR | Positive, n = 124 | Negative, n = 286 | p | OR | |
| Mortality, n (%) | 14 (11.2%) | 9 (3.2%) | 0.001 | 3.8 (1.6–9.1) | 15 (12.1%) | 8 (2.8%) | 0.000 | 4.7 (1.9–11.6) |
| Persistent multiorgan failure, n (%) | 20 (16%) | 11 (3.9%) | 0.000 | 4.7 (2.1–10.2) | 20 (16.1%) | 11 (3.8%) | 0.000 | 4.8 (2.2–10.3) |
| Severe AP, n (%) | 24 (19.2%) | 21 (7.4%) | 0.000 | 2.9 (1.5–5.6) | 33 (26.6%) | 12 (4.2%) | 0.000 | 8.2 (4.1–16.7) |
BISAP, Bedside Index for Severity in Acute Pancreatitis; APACHE-II, Acute Physiology and Chronic Health Evaluation-II; BUN, blood urea nitrogen; AP, acute pancreatitis.